Trial intelligence / Profile preview

Preoperative versus postoperative celecoxib for analgesia in total hip arthroplasty

ChiCTR2100049690Phase 4Completed

Sponsor
Daqing Oilfield General Hospital
Start
Jan 2018
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of celecoxib in hip osteoarthritis (2 arms), sponsored by Daqing Oilfield General Hospital. Primary endpoints: Visual analogue scale for pain and Harris hip score. Started Jan 2018; status: completed.

02

Drugs

celecoxib
03

Conditions

hip osteoarthritis

Beyond the preview

Go deeper on ChiCTR2100049690.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100049690.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call